(Circulation. 1999;99:1312-1317.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Heart Lung Institute (F.H.M.W., E.F.D.W., R.D., H.R., R.N.W.H., E.O.R.d.M.), Department of Cardiology, University Hospital Utrecht, Utrecht, Netherlands, and Department of Cardiology (A.A.M.W.), Academic Medical Center, Amsterdam, Netherlands.
Correspondence to Fred H.M. Wittkampf, PhD, Heart Lung Institute, Department of Cardiology, University Hospital Utrecht E03.829, PO Box 85500, 3508 GA, Utrecht, Netherlands. E-mail fredwittkampf{at}compuserve.com
| Abstract |
|---|
|
|
|---|
Methods and ResultsWe developed a new technique for online 3D localization of intracardiac electrodes. Regular catheter electrodes are used as sensors for a high-frequency transthoracic electrical field, which is applied via standard skin electrodes. We investigated localization accuracy within the right atrium, right ventricle, and left ventricle by comparing measured and true interelectrode distances of a decapolar catheter. Long-term stability was analyzed by localization of the most proximal His bundle before and after slow pathway ablation. Electrogram recordings were unaffected by the applied electrical field. Localization data from 3 catheter positions, widely distributed within the right atrium, right ventricle, or left ventricle, were analyzed in 10 patients per group. The relationship between measured and true electrode positions was highly linear, with an average correlation coefficient of 0.996, 0.997, and 0.999 for the right atrium, right ventricle, and left ventricle, respectively. Localization accuracy was better than 2 mm, with an additional scaling error of 8% to 14%. After 2 hours, localization of the proximal His bundle was reproducible within 1.4±1.1 mm.
ConclusionsThis new technique enables accurate and reproducible real-time localization of electrode positions in cardiac mapping and ablation procedures. Its application does not distort the quality of electrograms and can be applied to any electrode catheter.
Key Words: mapping catheter ablation electrophysiology
| Introduction |
|---|
|
|
|---|
Recently, a magnetic, nonfluoroscopic, catheter localization method was introduced.10 Its major limitation, however, is the mandatory use of a specific catheter design, which excludes other catheter types and brands. Moreover, multiple electrodes on the same catheter or electrodes on complex catheters cannot be localized.
We developed a new technique (LocaLisa) for real-time 3-dimensional (3D) localization of intracardiac catheter electrodes.11 This method uses an externally applied electrical field that is detected via standard catheter electrodes. The present study was performed to investigate the accuracy and limitations of this new electrode localization technique.
| Methods |
|---|
|
|
|---|
|
To apply this concept to catheter mapping and ablation procedures, the following requirements must be met: (1) the method must be applied in 3 orthogonal directions; (2) the externally applied electrical field must be harmless and must not interfere with electro(cardio)grams; (3) cyclic variations due to cardiac contraction and respiration must be offset; (4) the localization method must be stable throughout a catheterization procedure; and (5) the system must be calibrated to translate changes in recorded voltages into changes in electrode position.
Analogous to the Frank lead system,12 3 skin-electrode
pairs were used to send 3 small, 1-mA currents through the thorax in 3
orthogonal directions, with slightly different frequencies of
30 kHz
used for each direction (Figure 2
).
Standard surface ECG electrodes were placed at the right and left
midaxillary lines at the fourth intercostal space
(V2) level (X field) and at the left shoulder and
left leg (Y field). Two 10x15-cm skin patches, 1 anterior above the
heart at the V2 position and the other posterior
under the heart on the back, were used to create the Z field. Both
latter electrodes were chosen to be relatively large, because their
proximity to the heart was expected to create an otherwise too
inhomogeneous electrical field. The posterior skin patch
simultaneously served as the return electrode for RF
ablation. The 30-kHz signal was not expected to interfere with
electrophysiological recordings,
and the 1-mA current level was in accordance with international safety
standards.13
|
The mixture of 30-kHz signals, recorded from each catheter
electrode, was digitally separated to measure the amplitude of each of
the 3 frequency components. The 3 electrical field strengths were
calculated automatically by use of the difference in amplitudes
measured from neighboring electrode pairs with a known interelectrode
distance for
3 different spatial orientations of that dipole. We then
calculated the 3D position of each electrode by dividing each of the 3
amplitudes (V) by the corresponding electrical field strength
(V/cm).
The electrode positions were averaged over 1 or 2 seconds to reduce cyclic cardiac variations. Respiratory variations are too slow to be eliminated by averaging without compromising the real-time nature of the localization method, and their effect on localization accuracy is part of this study.
Device Specifications
The battery-powered LocaLisa system was designed and built at
our institute. By use of the above-mentioned orthogonal lead
configuration, 3 independent alternating currents of 1 mA were
delivered through the patient's chest, with 30.27 kHz, 30.70 kHz, and
31.15 kHz used for the X, Y, and Z directions, respectively (Figure 2
). The system had 2 input amplifiers for measuring the
resulting signal on 2 mapping catheter electrodes relative to a stable
skin or catheter reference electrode. The amplitudes of each of the 3
frequency components were optically transmitted to a Macintosh
computer. A custom-designed software application provided
moving-average filtering, calibration, and real-time display of the
position of the distal portion of the mapping catheter using 2 of its
electrodes (Figure 3
).
|
Study Protocol 1
All catheterization procedures were performed
with the patients in the fasting, nonsedated state. The first study
protocol was approved by our institution's ethics committee,
and informed consent was obtained from each patient. In 30 patients, a
deflectable decapolar electrode catheter (Marinr, Medtronic
CardioRhythm) was placed in a stable position within either the RA,
right ventricle (RV), or left ventricle (LV) in 10 different patients
for each group during the 30-minute observation period after a standard
catheter ablation procedure. Sequentially, each of the 10 electrodes
was connected to the LocaLisa system. Measurements were repeated at 2
other stable catheter positions within the same chamber. The 3 catheter
positions were chosen such that the electrode positions covered a major
portion of the cardiac chamber.
Total interelectrode spacing was 53.5 mm for the RA and RV catheters and 54 mm for the longer LV catheters, and all electrode positions and interelectrode distances were defined by use of the geometric center of each electrode.
Study Protocol 2
The magnitude of cyclic variations in the position of a
fluoroscopically and electrographically stable catheter-tip electrode
was measured in 30 patients in whom the LocaLisa system had been used
clinically during catheter mapping and ablation. Measurements were
performed within the RA, RV, and LV in 10 different patients per group.
With a stable catheter position, both this tip electrode and the tip
electrode of a coronary sinus (CS) catheter were connected to
the LocaLisa system with a right leg electrode used as a reference.
Measurements were taken once per second for 20 to 30 seconds.
Study Protocol 3
Long-term stability of the LocaLisa system was determined in 14
patients with AV nodal reentrant tachycardia by use of a
reference electrode in the CS or one of its side branches. The most
proximal His bundle recording site, characterized by a bipolar
His bundle deflection <50 µV and a negative deflection on the distal
unipolar electrogram only, was determined before and after posterior AV
nodal modification.
Calibration
In the first study, the 27 sets of interelectrode distances and
corresponding voltage amplitude differences that were obtained with the
3 catheter positions were used for automatic calibration. The 3
calculated field strengths (in mV/cm) thus reflect the average values
within the area covered by all 3 catheter positions.
In studies 2 and 3, calibration was performed automatically with the data obtained from the tip and the fourth (ring) electrodes of the mapping catheter at multiple catheter positions and orientations obtained during catheterization in the same chamber.
Data Analysis
With the decapolar catheters, positions along the catheter shaft
were calculated by summation of interelectrode distances. The accuracy
and linearity of the LocaLisa system were analyzed by
comparison of measured and true positions of the 10 electrodes for each
catheter position. With linear regression analysis, the slope
of the regression line between measured and true electrode positions,
the correlation coefficient, and the residual SD around the regression
line were calculated.
In study 2, the SDs of the recorded voltages (in 3 directions), measured at 1-second intervals, were divided by the corresponding field strength values to obtain the SD of the variations in electrode position.
In study 3, reproducibility of the localization method was determined by measurement of the difference between the 2 proximal His bundle positions, measured at the beginning and end of the ablation procedure.
All values are expressed as mean±SD.
| Results |
|---|
|
|
|---|
In study 1, only 2 stable catheter positions could be obtained in 2 patients of each ventricular group. Thus, in 30 patients, data of 30 RA, 28 RV, and 28 LV catheter positions were analyzed.
Measured interelectrode distances were plotted against true distances
for all catheter positions in each patient (Figure 4
). The relationship between measured and
true electrode distances was highly linear for all catheter positions,
with average correlation coefficients between 0.996 and 0.999 (Table 1
). This suggests that the
electrical fields were very homogeneous within the 53.5 or
54 mm covered by the catheter electrodes. The average slopes of
the regression lines were 0.99, 0.95, and 0.97, and the corresponding
average residual SDs around the regression line were 1.7, 1.3, and
1 mm for the RA, RV, and LV, respectively (Table 1
).
|
|
The magnitude of cyclic cardiac and respiratory variations in electrode
position was measured at fluoroscopically and electrographically stable
RA, RV, and LV catheter positions in 10 patients for each group (Table 2
). When a 2-second filter and a
right-leg reference electrode were used, the average SD of electrode
position was 1.3, 1.8, and 1.5 mm for the RA, RV, and LV,
respectively. The use of a CS reference electrode resulted in
significantly lower values of 0.8, 1.1, and 0.8 mm, respectively.
The low frequency and cyclic nature of the electrode movements
suggested that these variations were predominantly caused by
respiration.
|
We investigated the long-term stability of the LocaLisa system by comparing the most proximal His bundle recording site before and after slow pathway ablation in 14 patients with AV nodal reentrant tachycardia. Early in the study, the CS reference catheter in 2 patients migrated further into the vein during the course of the procedure, as was obvious from fluoroscopic images. In subsequent patients, we attempted to position the CS reference catheter in the middle cardiac vein or a more distal branch to ensure a stable position. Dislocation, however, also occurred in one of these patients. Data of these 3 patients were excluded from analysis. In the remaining 11 patients, the average distance between the preablation and postablation proximal His bundle location was 1.4±1.1 mm. There was no systematic drift in the system: the average change in position was +0.2±1.7 mm for the X, -0.1±0.3 mm for the Y, and +0.2±0.6 mm for the Z direction. The time interval between the 2 measurements was 128±82 minutes.
| Discussion |
|---|
|
|
|---|
Accuracy
Electrode localization with the LocaLisa system is potentially
affected by respiratory and cardiac movements, inhomogeneities of the
externally applied electrical field, and drift.
Respiratory and Cardiac Movements
In this study, we used a low-pass moving-average filter to
eliminate cyclic cardiac variations in the measured electrical signals.
The 2-second averaging period was felt to be an acceptable compromise
between localization accuracy and speed of response. We observed
relatively small cyclic variations in electrode position of 1 to 2
mm (Table 2
), which explains the similar residual SD around the
regression line measured in the first study. Averaging over a longer
time period not only would have reduced these variations but also would
have slowed down the response of the system to a sudden shift in
catheter position (Figure 5
). The results
of study 2 suggest that the use of a CS instead of a skin reference
electrode would have reduced these variations by a factor of
2
(Table 2
). Alternatively, this would allow for a reduction of
the averaging duration to 1 second and thus for a faster response of
the system to catheter movements (Figure 5
).
|
Inhomogeneity of the Electrical Field
Calibration with the data from all 30 electrodes, thus assuming a
homogeneous 3D electrical field within the entire cavity,
caused an 8% to 14% scaling error (Table 1
). This error must
be explained by inhomogeneity of the electrical field. This is of
little clinical relevance given that the region of interest is usually
limited to a few centimeters in cross section in which the scaling
error will affect all sites similarly. Moreover, all electrode
positions will remain uniquely identifiable with an error of 1 to
2 mm, which is acceptable given the size of regular mapping and
ablation electrodes and RF lesions.
Long-Term Stability
Measurement of the most proximal His bundle position revealed very
good reproducibility and stability of the localization method. However,
stability of the spatial reference catheter remains critically
important for any localization system. Future expansion of the LocaLisa
system to include more input channels will allow for a retrospective
switch to another reference electrode in case of dislocation. In
critical cases such as catheter ablation for ventricular
tachycardia, we have been using a 2F temporary
pacing wire with active fixation in the RV as a reference (model
6416, Medtronic CardioRhythm).
Clinical Implications
Except for the extra skin electrodes, the use of the LocaLisa
system only requires a mouse click or key stroke to mark successive
electrode positions. Since the completion of the present study, we
have used the device in >250 catheter mapping and ablation procedures
for various types of supraventricular and
ventricular tachyarrhythmias presently
amenable to catheter ablation. Different types and brands of
standard steerable electrode catheters were used with frequent catheter
exchange during procedures. In the ablation of accessory AV
pathways,2 15 18 19 20 21 sequential marking of
mapping/ablation sites often revealed spatial incompleteness in areas
that were difficult to access. Sites with transient block targeted the
site of successful ablation. Facilitation of repositioning of the
ablation electrode demonstrated its value after incomplete ablations
caused by catheter dislocation or early coagulum formation, especially
if these ablations had caused (transient?) interruption of the
accessory pathway. With atrial and ventricular
tachycardias, extra RF pulses could be applied closely
around an apparently successful ablation site to ensure elimination of
the arrhythmogenic area.22 23
The technique has been very helpful for a systematic, anatomically
guided approach in the treatment of AV nodal reentrant
tachycardia,24 25 26 avoiding repeated ablations
at the same location and ablations in close proximity to the most
proximal His bundle recording site. In patients with atrial
flutter, we use the system to delineate the region of interest (by
identifying His, CS ostium, and tricuspid annulus) and to create a line
of block in the lower RA isthmus (Figure 3
).
The current LocaLisa system can only measure the position of 2 electrodes simultaneously. With more input channels, the system would allow for real-time imaging of the electrode positions of more intracardiac catheters. This would give the catheterizing cardiologist a better perspective of the position of the mapping catheter relative to cardiac anatomic structures and allow for a substantial reduction in fluoroscopy time. More input channels would also allow for the use of more than one reference electrode, as discussed above.
Clinically, this new technique is and will be combined with RF delivery via the same electrode. With the first-generation device, the application of RF energy transiently disabled localization of the ablation electrode. Recently, dedicated filtering techniques have enabled continuous electrode localization during RF delivery.
Limitations
The accuracy of this localization technique has not yet been
investigated in the left atrial cavity. Transseptal punctures are not
often performed at our center, and 3 spatially different left atrial
catheter positions are very difficult to obtain via a retrograde aortic
approach. There is, however, little reason to expect less favorable
results in the left atrium. On the contrary, its more central position
within the thorax may be expected to result in a more
homogeneous electrical field and an even better
localization accuracy than in the other 3 chambers.
Conclusions
The LocaLisa technique allows for real-time, nonfluoroscopic, 3D
visualization of standard intracardiac catheter electrodes and is
sufficiently accurate for detailed catheter mapping and the creation of
linear or complex RF lesion patterns. Localization accuracy within the
RA and ventricular cavities is on the order of 1 to 2
mm. The gradient of the electrical field may cause an additional
scaling error of 8% to 14% within an entire cardiac cavity. Given a
stable reference electrode, the localization method is reliable during
catheterization procedures that last several hours.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received June 5, 1998; revision received November 12, 1998; accepted December 7, 1998.
| References |
|---|
|
|
|---|
2.
Calkins H, Langberg J, Sousa J, El-Atassi R, Leon A,
Kou W, Kaldfleisch S, Morady F. Radiofrequency catheter ablation of
accessory atrioventricular connections in 250 patients.
Circulation. 1992;85:13371346.
3.
Saoudi N, Atallah G, Kirkorian G, Touboul P. Catheter
ablation of the atrial myocardium in human type I atrial
flutter. Circulation. 1990;81:762771.
4.
Feld GK, Fleck RP, Chen P, Boyce K, Bahnson TD, Stein
JB, Calisi CM, Ibarra M. Radiofrequency catheter ablation for the
treatment of human type I atrial flutter. Circulation. 1992;86:12331240.
5. Cosio FG, Lopèz-Gil M, Goicolea A, Arribas F, Barroso JL. Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter. Am J Cardiol. 1993;71:705709.[Medline] [Order article via Infotrieve]
6.
Nakagawa H, Lazzara R, Khastgir T, Beckman KJ,
McClelland JH, Imai S, Pitha JV, Becker AE, Arruda M, Gonzales MD,
Widman LE, Rome M, Neuhauser J, Wang X, Calame JD, Goudeau MD, Jackman
WM. Role of the tricuspid annulus and the eustachian valve/ridge in
atrial flutter. Circulation. 1996;94:407424.
7. Swartz JF, Pellersels G, Silvers J, Patten, L, Cervantez D. A catheter-based curative approach to atrial fibrillation in humans. Circulation. 1994;90(suppl I):I-335. Abstract.
8.
Elvan A, Pride HP, Eble JN, Zipes DP. Radiofrequency
catheter ablation of the atria reduces inducibility and duration of
atrial fibrillation in dogs. Circulation. 1995;91:22352244.
9. Haïssaguerre M, Jaïs P, Shah DC, Gencel L, Pradeau V, Garrigues S, Chouairi S, Hocini M, le Métayer P, Roudaut R, Clémenty J. Right and left radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 1996;7:11321144.[Medline] [Order article via Infotrieve]
10. Ben-Haim SA, Osadchy D, Schuster I, Gepstein L, Hayam G, Josephson ME. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med. 1996;12:13931395.
11. Wittkampf FHM, inventor. Catheter mapping system and method. US patent 5697377. December 16, 1997.
12. Frank E. An accurate clinically practical system for spatial vectorcardiography. Circulation. 1956;13:737749.[Medline] [Order article via Infotrieve]
13. International Standard ICE 6011: Medical Electrical Equipment Part 1: General Requirements for Safety. 2nd ed. Geneva, Switzerland: Central Bureau of the International Electrotechnical Committee. 1988:8991.
14. Avital B, Helms RW, Kotov AW, Sieben W, Anderson W. The use of temperature versus local depolarization to monitor atrial lesion maturation during the creation of linear lesions in both atria. Circulation. 1996;94(suppl I):I-558. Abstract.
15. Borggrefe M, Budde T, Podczeck A, Breithardt G. High frequency alternating current ablation of an accessory pathway in humans. J Am Coll Cardiol. 1987;10:576582.[Abstract]
16. Wittkampf FHM, Hauer RNW, Robles de Medina EO. Radiofrequency ablation with a cooled porous electrode catheter. J Am Coll Cardiol. 1988;11:17A. Abstract.
17. Jenkins KJ, Walsh EP, Colan SD, Bergau DM, Saul JP, Lock JE. Multipolar endocardial mapping of the right atrium during cardiac catheterization: description of a new technique. J Am Coll Cardiol. 1993;22:11051110.[Abstract]
18. Weber H, Schmitz L. Catheter technique for closed-chest ablation of an accessory atrioventricular pathway. N Engl J Med. 1983;308:653654.[Medline] [Order article via Infotrieve]
19. Morady F, Scheinman MM. Transvenous catheter ablation of a posteroseptal accessory pathway in a patient with the Wolff-Parkinson-White syndrome. N Engl J Med. 1984;310:705707.[Medline] [Order article via Infotrieve]
20. Jackman WM, Wang X, Friday KJ, Roman CA, Moulton KP, Beckman KJ, McClelland JH, Twiidale N, Hazlitt HA, Prior MI, Margolis PD, Calame JD, Overholt ED, Lazzara R. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med. 1991;324:16051611.[Abstract]
21.
Schluter M, Greiger M, Siebels J, Duckeck W, Kuck KH.
Catheter ablation using radiofrequency current to cure
symptomatic patients with tachyarrhythmias
related to an accessory atrioventricular pathway.
Circulation. 1991;84:16441661.
22. Oeff M, Langberg JJ, Chin MC, Finkbeiner WE, Scheinman MM. Ablation of ventricular tachycardia using multiple sequential transcatheter application of radiofrequency energy. PACE Pacing Clin Electrophysiol. 1992;15:11671176.[Medline] [Order article via Infotrieve]
23. Elvan A, Wittkampf F, Wever E, Ramanna H, Derksen R, Magnin I, Hauer R, Robles de Medina E. Radiofrequency catheter ablation of ventricular tachycardia using a new nonfluoroscopic localization technique (LocaLisa). Circulation. 1998;98(suppl I):I-566. Abstract.
24. Jackman WM, Beckman KJ, McClelland JH, Wang X, Friday KJ, Roman CA, Moulton KP, Twidale N, Hazlitt HA, Prior MI, Oren J, Overholt ED, Lazzara R. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med. 1992;327:313318.[Abstract]
25. Wathen M, Natale A, Wolfe K, Newman D, Klein G. An anatomically guided approach to atrioventricular node slow pathway ablation. Am J Cardiol. 1992;70:886889.[Medline] [Order article via Infotrieve]
26.
Haïssaguerre M, Gaita F, Fischer B, Commenges
D, Montserrat P, d'Ivernois C, le Métayer P, Warin JF.
Elimination of atrioventricular nodal reentrant
tachycardia using discrete slow potentials to guide
application of radiofrequency energy. Circulation. 1992;85:21622175.
This article has been cited by other articles:
![]() |
E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Europace, June 1, 2009; 11(6): 771 - 817. [Full Text] [PDF] |
||||
![]() |
D. N. Stephens, M. O'Donnell, K. Thomenius, A. Dentinger, D. Wildes, P. Chen, K. K. Shung, J. Cannata, P. Khuri-Yakub, O. Oralkan, et al. Experimental Studies With a 9F Forward-Looking Intracardiac Imaging and Ablation Catheter J. Ultrasound Med., February 1, 2009; 28(2): 207 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Knackstedt, P. Schauerte, and P. Kirchhof Electro-anatomic mapping systems in arrhythmias Europace, November 1, 2008; 10(suppl_3): iii28 - iii34. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ruiz-Granell, A. Ferrero, S. Morell-Cabedo, A. Martinez-Brotons, V. Bertomeu, A. Llacer, and R. Garcia-Civera Implantation of single-lead atrioventricular permanent pacemakers guided by electroanatomic navigation without the use of fluoroscopy Europace, September 1, 2008; 10(9): 1048 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rao, Y. Ling, R. He, A. L. Gilbert, N. G. Frangogiannis, J. Wang, S. F. Nagueh, and D. S. Khoury Integrated multimodal-catheter imaging unveils principal relationships among ventricular electrical activity, anatomy, and function Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H1002 - H1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Arentz, R. Weber, G. Burkle, C. Herrera, T. Blum, J. Stockinger, J. Minners, F. J. Neumann, and D. Kalusche Small or Large Isolation Areas Around the Pulmonary Veins for the Treatment of Atrial Fibrillation?: Results From a Prospective Randomized Study Circulation, June 19, 2007; 115(24): 3057 - 3063. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace, June 1, 2007; 9(6): 335 - 379. [Full Text] [PDF] |
||||
![]() |
H. L. Estner, I. Deisenhofer, A. Luik, G. Ndrepepa, C. von Bary, B. Zrenner, and C. Schmitt Electrical isolation of pulmonary veins in patients with atrial fibrillation: reduction of fluoroscopy exposure and procedure duration by the use of a non-fluoroscopic navigation system (NavX(R)) Europace, August 1, 2006; 8(8): 583 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dong, H. Calkins, S. B. Solomon, S. Lai, D. Dalal, A. Lardo, E. Brem, A. Preiss, R. D. Berger, H. Halperin, et al. Integrated Electroanatomic Mapping With Three-Dimensional Computed Tomographic Images for Real-Time Guided Ablations Circulation, January 17, 2006; 113(2): 186 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Triedman Virtual Reality in Interventional Electrophysiology Circulation, December 13, 2005; 112(24): 3677 - 3679. [Full Text] [PDF] |
||||
![]() |
J. Sra Registration of three dimensional left atrial images with interventional systems Heart, August 1, 2005; 91(8): 1098 - 1104. [Full Text] [PDF] |
||||
![]() |
M. Rotter, Y. Takahashi, P. Sanders, M. Haissaguerre, P. Jais, L.-F. Hsu, F. Sacher, J.-L. Pasquie, J. Clementy, and M. Hocini Reduction of fluoroscopy exposure and procedure duration during ablation of atrial fibrillation using a novel anatomical navigation system Eur. Heart J., July 2, 2005; 26(14): 1415 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.P. Kimman, D.A.M.J. Theuns, T. Szili-Torok, M.F. Scholten, J.C. Res, and L.J. Jordaens CRAVT: a prospective, randomized study comparing transvenous cryothermal and radiofrequency ablation in atrioventricular nodal re-entrant tachycardia Eur. Heart J., December 2, 2004; 25(24): 2232 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.A. Simmers and R. Tukkie How to perform pulmonary vein isolation for the treatment of atrial fibrillation: use of the LocaLisa catheter navigation system Europace, January 1, 2004; 6(2): 92 - 96. [Full Text] [PDF] |
||||
![]() |
J. Kammeraad, F. U. ten Cate, T. Simmers, M. Emmel, F. H.M. Wittkampf, and N. Sreeram Radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia in children aided by the LocaLisa mapping system Europace, January 1, 2004; 6(3): 209 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dickfeld, H. Calkins, M. Zviman, R. Kato, G. Meininger, L. Lickfett, R. Berger, H. Halperin, and S. B. Solomon Anatomic Stereotactic Catheter Ablation on Three-Dimensional Magnetic Resonance Images in Real Time Circulation, November 11, 2003; 108(19): 2407 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Wetzel, G. Hindricks, P. Schirdewahn, A. Dorszewski, A. Fleck, F. Heinke, and H. Kottkamp A stepwise mapping approach for localization and ablation of ectopic right, left, and septal atrial foci using electroanatomic mapping Eur. Heart J., September 1, 2002; 23(17): 1387 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Manolis, T. Maounis, V. Vassilikos, J. Chiladakis, and D. V. Cokkinos Arrhythmia recurrences are rare when the site of radiofrequency ablation of the slow pathway is medial or anterior to the coronary sinus os Europace, January 1, 2002; 4(2): 193 - 199. [Full Text] [PDF] |
||||
![]() |
D W. DAVIES Catheter ablation of ventricular tachycardia: are there limits? Heart, December 1, 2000; 84(6): 585 - 586. [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |